Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

Italy

Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Alessandria

Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, BO

Azienda Sanitaria Ospedaliera Santa Croce e Carle di Cuneo, Cuneo, Cuneo

Ospedale San Raffaele, Milan, MILANO

Istituto Nazionale dei Tumori, Milan, MILANO

Irccs Istituto Clinico Humanitas, Rozzano, MILANO

AOU Policlinico Umberto I, Roma, RO